January 29, 2024
Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn’s disease
Bian et al. (2017) RPTH 7, doi: 10.1002/dta.2250 Therapeutic drug monitoring of adalimumab is recommended…